Burkitt lymphoma is an aggressive cancer that starts in B cells, which are part of the immune system. It can lead to death, but intensive treatment can improve the likelihood of long-term survival. In ...

An international research study involving the University of Nebraska Medical Center, the National Cancer Institute and 10 other institutions has successfully identified the gene expression signature ...

A study has found strong similarities between children with endemic Burkitt lymphoma — an aggressive cancer that attacks the body's defense system and children with silent malaria infection. Endemic ...

Burkitt's lymphoma is a rarely encountered, aggressive B-cell lymphoma that is highly curable in children and young adults. In middle-aged and older adults, however, administering curative therapy may ...

A 72-year-old patient with Burkitt lymphoma was successfully treated with nivolumab after standard-of-care chemotherapy failed. A new case report is raising the possibility that nivolumab (Opdivo) may ...

Burkitt lymphoma is a highly aggressive B-cell non-Hodgkin lymphoma whose diagnosis relies on integrated clinical, pathological, and imaging assessments. Established diagnostic criteria include ...

Adult patients with Burkitt lymphoma can achieve equally sound survival outcomes with dose-adjusted chemotherapy vs high-intensity regimens, but can do so while avoiding the severe toxicities, US ...

JOHNSON CITY, Tenn. (WCYB) — A Johnson City boy diagnosed with a rare form of lymphoma received the ultimate game room, thanks to the Make-A-Wish Foundation. Brayden Arnold, 9, was diagnosed with ...

The "Global Burkitt Lymphoma Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The Global Burkitt Lymphoma Market to grow at a CAGR of 3.07% during the period ...

SELMA, N.C. -- A North Carolina family said their prayers were answered after their 5-year-old, Holly Carter, beat a devastating diagnosis, and now they are getting ready to celebrate in a big way.